Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 3 |
GO:0043226 | organelle | 2 | 3 |
GO:0043227 | membrane-bounded organelle | 3 | 3 |
GO:0043229 | intracellular organelle | 3 | 3 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: E9ADI2
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 3 |
GO:0006089 | lactate metabolic process | 4 | 3 |
GO:0008152 | metabolic process | 1 | 3 |
GO:0009056 | catabolic process | 2 | 3 |
GO:0009987 | cellular process | 1 | 3 |
GO:0016054 | organic acid catabolic process | 4 | 3 |
GO:0019752 | carboxylic acid metabolic process | 5 | 3 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 3 |
GO:0043436 | oxoacid metabolic process | 4 | 3 |
GO:0044237 | cellular metabolic process | 2 | 3 |
GO:0044248 | cellular catabolic process | 3 | 3 |
GO:0044281 | small molecule metabolic process | 2 | 3 |
GO:0044282 | small molecule catabolic process | 3 | 3 |
GO:0046395 | carboxylic acid catabolic process | 5 | 3 |
GO:0071704 | organic substance metabolic process | 2 | 3 |
GO:0072329 | monocarboxylic acid catabolic process | 6 | 3 |
GO:1901575 | organic substance catabolic process | 3 | 3 |
GO:1901615 | organic hydroxy compound metabolic process | 3 | 3 |
GO:1901616 | organic hydroxy compound catabolic process | 4 | 3 |
GO:1903457 | lactate catabolic process | 5 | 3 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 13 |
GO:0003824 | catalytic activity | 1 | 13 |
GO:0004457 | lactate dehydrogenase activity | 4 | 3 |
GO:0004458 | D-lactate dehydrogenase (cytochrome) activity | 5 | 3 |
GO:0005488 | binding | 1 | 13 |
GO:0008720 | D-lactate dehydrogenase activity | 5 | 3 |
GO:0016491 | oxidoreductase activity | 2 | 3 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3 | 3 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4 | 3 |
GO:0016898 | oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor | 4 | 3 |
GO:0036094 | small molecule binding | 2 | 13 |
GO:0043167 | ion binding | 2 | 13 |
GO:0043168 | anion binding | 3 | 13 |
GO:0050660 | flavin adenine dinucleotide binding | 4 | 13 |
GO:0071949 | FAD binding | 5 | 13 |
GO:0097159 | organic cyclic compound binding | 2 | 13 |
GO:1901265 | nucleoside phosphate binding | 3 | 13 |
GO:1901363 | heterocyclic compound binding | 2 | 13 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 247 | 251 | PF00656 | 0.389 |
CLV_NRD_NRD_1 | 133 | 135 | PF00675 | 0.446 |
CLV_NRD_NRD_1 | 201 | 203 | PF00675 | 0.493 |
CLV_NRD_NRD_1 | 29 | 31 | PF00675 | 0.413 |
CLV_NRD_NRD_1 | 345 | 347 | PF00675 | 0.337 |
CLV_PCSK_KEX2_1 | 310 | 312 | PF00082 | 0.405 |
CLV_PCSK_KEX2_1 | 345 | 347 | PF00082 | 0.337 |
CLV_PCSK_KEX2_1 | 427 | 429 | PF00082 | 0.351 |
CLV_PCSK_PC1ET2_1 | 310 | 312 | PF00082 | 0.331 |
CLV_PCSK_PC1ET2_1 | 427 | 429 | PF00082 | 0.395 |
CLV_PCSK_SKI1_1 | 135 | 139 | PF00082 | 0.406 |
CLV_PCSK_SKI1_1 | 145 | 149 | PF00082 | 0.434 |
CLV_PCSK_SKI1_1 | 18 | 22 | PF00082 | 0.409 |
CLV_PCSK_SKI1_1 | 186 | 190 | PF00082 | 0.341 |
CLV_PCSK_SKI1_1 | 286 | 290 | PF00082 | 0.315 |
CLV_PCSK_SKI1_1 | 30 | 34 | PF00082 | 0.400 |
CLV_PCSK_SKI1_1 | 318 | 322 | PF00082 | 0.371 |
CLV_PCSK_SKI1_1 | 424 | 428 | PF00082 | 0.436 |
CLV_PCSK_SKI1_1 | 466 | 470 | PF00082 | 0.301 |
DEG_SIAH_1 | 61 | 69 | PF03145 | 0.337 |
DOC_CKS1_1 | 187 | 192 | PF01111 | 0.337 |
DOC_CKS1_1 | 87 | 92 | PF01111 | 0.337 |
DOC_MAPK_gen_1 | 202 | 210 | PF00069 | 0.464 |
DOC_MAPK_gen_1 | 424 | 432 | PF00069 | 0.455 |
DOC_MAPK_MEF2A_6 | 179 | 187 | PF00069 | 0.337 |
DOC_PP2B_LxvP_1 | 405 | 408 | PF13499 | 0.389 |
DOC_USP7_MATH_1 | 244 | 248 | PF00917 | 0.424 |
DOC_USP7_MATH_1 | 251 | 255 | PF00917 | 0.362 |
DOC_USP7_MATH_1 | 280 | 284 | PF00917 | 0.454 |
DOC_USP7_MATH_1 | 352 | 356 | PF00917 | 0.376 |
DOC_USP7_UBL2_3 | 321 | 325 | PF12436 | 0.430 |
DOC_USP7_UBL2_3 | 34 | 38 | PF12436 | 0.442 |
DOC_USP7_UBL2_3 | 387 | 391 | PF12436 | 0.393 |
DOC_WW_Pin1_4 | 186 | 191 | PF00397 | 0.337 |
DOC_WW_Pin1_4 | 86 | 91 | PF00397 | 0.337 |
LIG_14-3-3_CanoR_1 | 140 | 149 | PF00244 | 0.389 |
LIG_14-3-3_CanoR_1 | 202 | 210 | PF00244 | 0.464 |
LIG_14-3-3_CanoR_1 | 345 | 353 | PF00244 | 0.453 |
LIG_14-3-3_CanoR_1 | 356 | 363 | PF00244 | 0.292 |
LIG_BRCT_BRCA1_1 | 116 | 120 | PF00533 | 0.315 |
LIG_FHA_1 | 110 | 116 | PF00498 | 0.337 |
LIG_FHA_1 | 195 | 201 | PF00498 | 0.421 |
LIG_FHA_1 | 218 | 224 | PF00498 | 0.350 |
LIG_FHA_1 | 357 | 363 | PF00498 | 0.372 |
LIG_FHA_1 | 373 | 379 | PF00498 | 0.354 |
LIG_FHA_1 | 421 | 427 | PF00498 | 0.389 |
LIG_FHA_2 | 12 | 18 | PF00498 | 0.478 |
LIG_FHA_2 | 175 | 181 | PF00498 | 0.339 |
LIG_FHA_2 | 298 | 304 | PF00498 | 0.329 |
LIG_FHA_2 | 379 | 385 | PF00498 | 0.381 |
LIG_FHA_2 | 434 | 440 | PF00498 | 0.315 |
LIG_FHA_2 | 93 | 99 | PF00498 | 0.373 |
LIG_Integrin_RGD_1 | 191 | 193 | PF01839 | 0.315 |
LIG_LIR_Gen_1 | 312 | 320 | PF02991 | 0.280 |
LIG_LIR_Gen_1 | 400 | 409 | PF02991 | 0.412 |
LIG_LIR_LC3C_4 | 37 | 42 | PF02991 | 0.390 |
LIG_LIR_Nem_3 | 226 | 232 | PF02991 | 0.453 |
LIG_LIR_Nem_3 | 312 | 316 | PF02991 | 0.337 |
LIG_LIR_Nem_3 | 317 | 323 | PF02991 | 0.337 |
LIG_LIR_Nem_3 | 400 | 406 | PF02991 | 0.422 |
LIG_SH2_NCK_1 | 380 | 384 | PF00017 | 0.331 |
LIG_SH2_SRC | 313 | 316 | PF00017 | 0.299 |
LIG_SH2_STAP1 | 22 | 26 | PF00017 | 0.392 |
LIG_SH2_STAT3 | 481 | 484 | PF00017 | 0.402 |
LIG_SH2_STAT5 | 214 | 217 | PF00017 | 0.359 |
LIG_SH2_STAT5 | 284 | 287 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 315 | 318 | PF00017 | 0.486 |
LIG_SH2_STAT5 | 331 | 334 | PF00017 | 0.397 |
LIG_SH2_STAT5 | 380 | 383 | PF00017 | 0.389 |
LIG_SH3_3 | 184 | 190 | PF00018 | 0.337 |
LIG_SH3_3 | 364 | 370 | PF00018 | 0.372 |
LIG_SH3_3 | 84 | 90 | PF00018 | 0.337 |
LIG_SUMO_SIM_anti_2 | 72 | 79 | PF11976 | 0.348 |
LIG_SUMO_SIM_par_1 | 293 | 298 | PF11976 | 0.297 |
LIG_SUMO_SIM_par_1 | 43 | 51 | PF11976 | 0.597 |
LIG_TRAF2_1 | 14 | 17 | PF00917 | 0.510 |
LIG_TRAF2_1 | 70 | 73 | PF00917 | 0.389 |
LIG_TRFH_1 | 229 | 233 | PF08558 | 0.416 |
LIG_UBA3_1 | 46 | 52 | PF00899 | 0.393 |
MOD_CDK_SPK_2 | 186 | 191 | PF00069 | 0.331 |
MOD_CDK_SPK_2 | 86 | 91 | PF00069 | 0.372 |
MOD_CK1_1 | 155 | 161 | PF00069 | 0.343 |
MOD_CK1_1 | 168 | 174 | PF00069 | 0.245 |
MOD_CK1_1 | 217 | 223 | PF00069 | 0.351 |
MOD_CK1_1 | 372 | 378 | PF00069 | 0.338 |
MOD_CK2_1 | 11 | 17 | PF00069 | 0.495 |
MOD_CK2_1 | 174 | 180 | PF00069 | 0.337 |
MOD_CK2_1 | 203 | 209 | PF00069 | 0.455 |
MOD_CK2_1 | 331 | 337 | PF00069 | 0.403 |
MOD_CK2_1 | 378 | 384 | PF00069 | 0.340 |
MOD_CK2_1 | 433 | 439 | PF00069 | 0.315 |
MOD_CK2_1 | 48 | 54 | PF00069 | 0.462 |
MOD_CK2_1 | 66 | 72 | PF00069 | 0.266 |
MOD_CK2_1 | 92 | 98 | PF00069 | 0.337 |
MOD_DYRK1A_RPxSP_1 | 186 | 190 | PF00069 | 0.372 |
MOD_GlcNHglycan | 165 | 168 | PF01048 | 0.347 |
MOD_GlcNHglycan | 205 | 208 | PF01048 | 0.486 |
MOD_GlcNHglycan | 237 | 240 | PF01048 | 0.371 |
MOD_GlcNHglycan | 333 | 336 | PF01048 | 0.403 |
MOD_GlcNHglycan | 350 | 353 | PF01048 | 0.512 |
MOD_GlcNHglycan | 436 | 439 | PF01048 | 0.340 |
MOD_GSK3_1 | 109 | 116 | PF00069 | 0.434 |
MOD_GSK3_1 | 161 | 168 | PF00069 | 0.330 |
MOD_GSK3_1 | 231 | 238 | PF00069 | 0.381 |
MOD_GSK3_1 | 280 | 287 | PF00069 | 0.382 |
MOD_GSK3_1 | 340 | 347 | PF00069 | 0.443 |
MOD_GSK3_1 | 348 | 355 | PF00069 | 0.389 |
MOD_GSK3_1 | 48 | 55 | PF00069 | 0.400 |
MOD_LATS_1 | 354 | 360 | PF00433 | 0.226 |
MOD_N-GLC_2 | 124 | 126 | PF02516 | 0.372 |
MOD_NEK2_1 | 162 | 167 | PF00069 | 0.366 |
MOD_NEK2_1 | 208 | 213 | PF00069 | 0.420 |
MOD_NEK2_1 | 297 | 302 | PF00069 | 0.367 |
MOD_NEK2_1 | 432 | 437 | PF00069 | 0.429 |
MOD_NEK2_2 | 169 | 174 | PF00069 | 0.337 |
MOD_NEK2_2 | 344 | 349 | PF00069 | 0.449 |
MOD_PIKK_1 | 208 | 214 | PF00454 | 0.412 |
MOD_PKA_1 | 202 | 208 | PF00069 | 0.475 |
MOD_PKA_2 | 201 | 207 | PF00069 | 0.469 |
MOD_PKA_2 | 344 | 350 | PF00069 | 0.454 |
MOD_Plk_1 | 208 | 214 | PF00069 | 0.412 |
MOD_Plk_4 | 263 | 269 | PF00069 | 0.364 |
MOD_ProDKin_1 | 186 | 192 | PF00069 | 0.337 |
MOD_ProDKin_1 | 86 | 92 | PF00069 | 0.337 |
MOD_SUMO_rev_2 | 417 | 426 | PF00179 | 0.373 |
TRG_ENDOCYTIC_2 | 242 | 245 | PF00928 | 0.389 |
TRG_ENDOCYTIC_2 | 313 | 316 | PF00928 | 0.429 |
TRG_ENDOCYTIC_2 | 480 | 483 | PF00928 | 0.301 |
TRG_ER_diArg_1 | 258 | 261 | PF00400 | 0.389 |
TRG_PTS1 | 490 | 493 | PF00515 | 0.480 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6Q0 | Leptomonas seymouri | 25% | 95% |
A0A0N1PE88 | Leptomonas seymouri | 75% | 99% |
A0A0N1PEY1 | Leptomonas seymouri | 24% | 79% |
A0A0S4IT80 | Bodo saltans | 24% | 100% |
A0A0S4JD99 | Bodo saltans | 54% | 100% |
A0A0S4JV88 | Bodo saltans | 24% | 78% |
A0A1X0NXE7 | Trypanosomatidae | 25% | 95% |
A0A1X0P026 | Trypanosomatidae | 66% | 100% |
A0A1X0P2J0 | Trypanosomatidae | 23% | 80% |
A0A3Q8IDH3 | Leishmania donovani | 61% | 100% |
A0A3Q8IDH5 | Leishmania donovani | 99% | 100% |
A0A3Q8IEJ5 | Leishmania donovani | 24% | 95% |
A0A3Q8IRN9 | Leishmania donovani | 22% | 79% |
A0A422N649 | Trypanosoma rangeli | 22% | 80% |
A0A422N8Z9 | Trypanosoma rangeli | 26% | 95% |
A1L258 | Danio rerio | 25% | 92% |
A4HCV1 | Leishmania braziliensis | 25% | 94% |
A4HFX9 | Leishmania braziliensis | 87% | 100% |
A4HHV7 | Leishmania braziliensis | 23% | 79% |
A4I0D2 | Leishmania infantum | 24% | 95% |
A4I309 | Leishmania infantum | 99% | 100% |
A4I481 | Leishmania infantum | 61% | 100% |
A4I507 | Leishmania infantum | 22% | 79% |
A4VGK4 | Pseudomonas stutzeri (strain A1501) | 27% | 100% |
B8B7X6 | Oryza sativa subsp. indica | 26% | 88% |
C9ZQF7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 22% | 80% |
D4MUV9 | Anaerostipes hadrus | 33% | 100% |
E9ADN0 | Leishmania major | 61% | 100% |
E9AM50 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 61% | 100% |
E9AW96 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 23% | 95% |
E9AZA6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
E9B0D7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 23% | 79% |
F1QXM5 | Danio rerio | 34% | 99% |
H6LBS1 | Acetobacterium woodii (strain ATCC 29683 / DSM 1030 / JCM 2381 / KCTC 1655 / WB1) | 28% | 100% |
O23240 | Arabidopsis thaliana | 23% | 88% |
O29853 | Archaeoglobus fulgidus (strain ATCC 49558 / DSM 4304 / JCM 9628 / NBRC 100126 / VC-16) | 31% | 100% |
O45218 | Caenorhabditis elegans | 25% | 83% |
O96759 | Dictyostelium discoideum | 24% | 81% |
O97157 | Trypanosoma brucei brucei | 22% | 80% |
P0AEP9 | Escherichia coli (strain K12) | 30% | 99% |
P0AEQ0 | Escherichia coli O6:H1 (strain CFT073 / ATCC 700928 / UPEC) | 30% | 99% |
P0DV35 | Xanthomonas citri pv. viticola (strain LMG 965 / NCPPB 2475 / ICMP 3867 / CFBP 7660) | 28% | 100% |
P32891 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 29% | 84% |
P39976 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 25% | 99% |
P46681 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 26% | 93% |
P84850 | Rattus norvegicus | 24% | 92% |
P94535 | Bacillus subtilis (strain 168) | 31% | 100% |
P9WIT0 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 29% | 100% |
P9WIT1 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 29% | 100% |
Q12627 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 30% | 86% |
Q1JPD3 | Bos taurus | 25% | 91% |
Q46911 | Escherichia coli (strain K12) | 25% | 100% |
Q4QB82 | Leishmania major | 23% | 95% |
Q7TNG8 | Mus musculus | 35% | 100% |
Q7XI14 | Oryza sativa subsp. japonica | 26% | 88% |
Q7YWB6 | Leishmania major | 22% | 79% |
Q86WU2 | Homo sapiens | 34% | 97% |
Q8CIM3 | Mus musculus | 24% | 92% |
Q8N465 | Homo sapiens | 25% | 95% |
Q8X7S0 | Escherichia coli O157:H7 | 25% | 100% |
Q94AX4 | Arabidopsis thaliana | 33% | 87% |
Q9C1X2 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 23% | 94% |
V5BCB2 | Trypanosoma cruzi | 23% | 80% |
V5D7M3 | Trypanosoma cruzi | 24% | 98% |